Log In
Print this Print this

IV FluCide (NV-INF-1)

  Manage Alerts
Collapse Summary General Information
Company NanoViricides Inc.
DescriptionNanoviricide designed to bind to the region of hemagglutinin that binds to the native sialic acid receptor
Molecular Target
Mechanism of Action 
Therapeutic ModalityNanotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationInfluenza virus
Indication DetailsPrevent influenza A (H1N1) virus infection; Treat influenza A (H1N1) virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today